Regulation of estrogen receptor and epidermal growth factor receptor by tamoxifen under high and low estrogen environments in MCF-7 cells grown in athymic mice

Oncology Reports

Volumn 7, Issue 1, 2000, Pages 135-140

  Koibuchi, Yukio ^a   Iino, Yuichi ^a   Uchida, Tsutomu ^a   Andoh, Tatsumasa ^a   Horii, Yoshio ^a   Nagasawa, Masahiro ^a   Horiguchi, Jun ^a   Maemura, Michio ^a   Takei, Hiroyuki ^a   Yokoe, Takao ^a   Morishita, Yasuo ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

17 estradiol; Breast cancer; Epidermal growth factor receptor; Estrogen recepor; Tamoxifen

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTRADIOL; ESTROGEN RECEPTOR; TAMOXIFEN; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; CHEMISTRY; EXPERIMENTAL NEOPLASM; FEMALE; HUMAN; MOUSE; NUDE MOUSE; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; ESTRADIOL; FEMALE; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ESTROGEN; TAMOXIFEN; TRANSFORMING GROWTH FACTOR ALPHA; TRANSPLANTATION, HETEROLOGOUS;

EID: 0033628456     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.7.1.135     Document Type: Article

References (23)

1. Sainsbury JRC, Farndon JR, Needham GK, Malcolm AJ and Harris AL: Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet i: 1398-1402, 1987.
2. Nicholson S, Sainsbury JRC, Halcrow P, Kelly P, Angus B, Wright C, Henry J, Farndon JR and Harris AL: Epidermal growth factor receptor (EGFr): results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup. Br J Cancer 63: 146-150, 1991.
3. Fox SB, Smith K, Hollyer J, Greenall M, Hastrich D and Harris AL: The epidermal growth factor receptor as a prognostic marker: results of 370 patients and review of 3009 patients. Breast Cancer Res Treat 29: 41-49, 1994.
4. Toi M, Tominaga T, Osaki A and Toge T: Role of epidermal growth factor receptor expression in primary breast cancer: results of a biochemical study and an immunocytochemical study. Breast Cancer Res Treat 29: 51-58, 1994.
5. Gasparini G, Boracchi P, Bevilacqua P, Mezzetti M, Pozza F and Weidner N: A multiparametric study on the prognostic value of epidermal growth factor receptor in operable breast carcinoma. Breast Cancer Res Treat 29: 51-58, 1994.
6. Newby JC, A'Hern RP, Leek RD, Smith IE, Harris AL and Dowsett M: Br J Cancer 71: 1237-1242, 1995.
7. Fitzpatrick SL, Brightwell J, Wittliff J, Barrows GH and Schultz GS: Epidermal growth factor binding by breast biopsies and relationship to estrogen and progestin receptor levels. Cancer Res 44: 3448-3453, 1984.
8. Sainsbury JRC, Farndon JR, Sherbet GV and Harris AL: Epidermal growth factor receptors and oestrogen receptors in human breast cancers. Lancet i: 364-366, 1985.
9. Koenders, PG, Beek LVAM, Guerts-Moespot A, Heuvel JJTM, Kienhuis CBM and Benraad TJ: Epidermal growth factor receptor-negative tumors are predominantly confined to the subgroup of estradiol receptor-positive human primary breast cancers. Cancer Res 51: 4544-4548, 1991.
10. Berthois Y, Dong XF and Martin PM: Regulation of epidermal growth factor receptor by estrogen and antiestrogen in the human breast cancer cell line MCF-7. Biochem Biophys Res Commun 159: 126-131, 1989.
11. Wolf DM and Jordan VC: Characterization of tamoxifen stimulated MCF-7 tumor variants grown in athymic mice. Breast Cancer Res Treat 31: 117-127, 1994.
12. Yarden RI, Lauber AH, El Ashry D and Chrysogelos SA: Biomodal regulation of epidermal growth factor receptor by estrogen in breast cancer cells. Endocrinology 137: 2739-2747, 1996.
13. Kiang DT, Kollander RE, Thomas T and Kennedy BJ: Up-regulation of estrogen receptors by non-steroidal antiestrogens in human breast cancer. Cancer Res 49: 5312-5316, 1989.
14. Clarke RB, Laidlaw IJ, Jones LJ, Howell A and Anderson E: Effect of tamoxifen on Ki67 labeling index in human breast tumors and its relationship to oestrogen and progesterone receptor status. Br J Cancer 67: 606-611, 1993.
15. Noguchi S, Motomura K, Inaji H, Imaoka S and Koyama H: Up-regulation of estrogen receptor by tamoxifen in human breast cancer. Cancer 71: 1266-1272, 1993.
16. McClelland RA, Manning DL, Gee JMW, Anderson E, Clarke R, Howell A, Dowsett M, Robertson JFR, Blarney RW, Wakeling AE and Nicholson RI: Effects of short-term antiestrogen treatment of primary breast cancer on estrogen receptor mRNA and protein expression and on estrogen-regulated genes. Breast Cancer Res Treat 41: 31-41, 1996.
17. Derynck R, Goddel DV, Ullrich A, Guttreman JU, Williams RD, Bringman TS and Berger WH: Synthesis of mRNAs for TGF-α and β and epidermal growth factor receptor by human tumors. Cancer Res 47: 707-712, 1987.
18. DiMarco E, Pierce JH, Fleming TP, Kraus MH, Molloy CJ, Aaronson SA and DiFiore PP: Autocrine interaction between TGF-α and EGF-receptor: quantitative requirements for induction of the malignant phenotype. Oncogene 4: 831-839, 1990.
19. Lippman ME and Dickson RB: Mechanisms of growth control in normal and malignant breast epithelium. Rec Prog Horm Res 45: 383-440, 1989.
20. Noguchi S, Motomura K, Inaji H, Imaoka S and Koyama H: Down-regulation of transforming growth factor-α by tamoxifen in human breast cancer. Cancer 72: 131-136, 1993.
21. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
22. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
23. Katzenellenbogen BS, Montano MM, Ekena K, Herman ME and McInerney E: Antiestrogens: mechanisms of action and resistance in breast cancer. Breast Cancer Res and Treat 44: 23-38, 1997.